{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:12:16Z","timestamp":1773292336515,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1136\/annrheumdis-2011-200848","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T05:46:48Z","timestamp":1331790408000},"page":"1666-1670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis"],"prefix":"10.1016","volume":"71","author":[{"given":"Marja-Kaisa","family":"Koivula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Heli\u00f6vaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harri","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Palosuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Knekt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Immonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Risteli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2011-200848_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/ard.2004.031211","article-title":"Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?","volume":"64","author":"Koivula","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200848_bib2","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1515\/CCLM.2005.239","article-title":"Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis","volume":"43","author":"Koivula","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1136\/annrheumdis-2011-200848_bib3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/ard.2006.062919","article-title":"Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis","volume":"66","author":"Koivula","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200848_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/BOR.0b013e32832a2e44","article-title":"What happens before the onset of rheumatoid arthritis?","volume":"21","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200848_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/art.1780280503","article-title":"When does rheumatoid disease start?","volume":"28","author":"Aho","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200848_bib6","first-page":"2743","article-title":"Antifilaggrin antibodies within \u2018normal\u2019 range predict rheumatoid arthritis in a linear fashion","volume":"27","author":"Aho","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200848_bib7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780350810","article-title":"Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease","volume":"35","author":"Kurki","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200848_bib8","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200848_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2903","article-title":"The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis","volume":"12","author":"Pruijn","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-200848_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2011-200848_bib11","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","article-title":"Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis","volume":"63","author":"Van de Stadt","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200848_bib12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200848_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2004.07.016","article-title":"Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker","volume":"350","author":"Nijenhuis","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1136\/annrheumdis-2011-200848_bib14","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200848_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","article-title":"The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis","volume":"50","author":"Van Steendam","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-200848_bib16","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200848_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","article-title":"Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis","volume":"34","author":"Poulsom","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1136\/annrheumdis-2011-200848_bib18","first-page":"1658","article-title":"Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis","volume":"34","author":"So\u00f3s","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200848_bib19","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar2362","article-title":"Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study","volume":"10","author":"Ursum","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-200848_bib20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00296-009-0854-2","article-title":"Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis","volume":"29","author":"Wagner","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1136\/annrheumdis-2011-200848_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","article-title":"Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review","volume":"69","author":"Luime","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200848_bib22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/rheumatology\/kel113","article-title":"Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis","volume":"45","author":"Koivula","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-200848_bib23","first-page":"1830","article-title":"Smoking and risk of rheumatoid arthritis","volume":"20","author":"Heli\u00f6vaara","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200848_bib24","first-page":"1674","article-title":"The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement","volume":"20","author":"Hakala","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200848_bib25","first-page":"537","article-title":"Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975\u20131990","volume":"14","author":"Kaipiainen-Sepp\u00e4nen","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200848_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/oxfordjournals.aje.a114788","article-title":"Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up","volume":"127","author":"Knekt","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1136\/annrheumdis-2011-200848_bib27","first-page":"5","article-title":"Statistical methods in cancer research: Volume I. The analysis of case\u2013control studies","volume":"32","author":"Breslow","year":"1980","journal-title":"IARC Sci Publ"},{"key":"10.1136\/annrheumdis-2011-200848_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/07853890410026025","article-title":"Risk factors for rheumatoid arthritis","volume":"36","author":"Aho","year":"2004","journal-title":"Ann Med"},{"key":"10.1136\/annrheumdis-2011-200848_bib29","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","article-title":"Peptidylarginine deiminase from Porphyromonasgingivalis citrullinates human fibrinogen and \u03b1-enolase: implications for autoimmunity in rheumatoid arthritis","volume":"62","author":"Wegner","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200848_bib30","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat Med"},{"key":"10.1136\/annrheumdis-2011-200848_bib31","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/art.27644","article-title":"Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits","volume":"62","author":"Turunen","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2011-200848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:03:27Z","timestamp":1737248607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724186682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0003496724186682"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200848","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}